Terumo Corp.

Company Overview

Terumo Corp. manufactures and commercializes medical products and equipment. It operates through its three reportable segments: the cardiac and vascular segment, the medical care solutions segment, and the blood and cell technologies segment. It provides solutions to various healthcare sectors, including pharmaceuticals, nutritional food supplements, disposable medical devices, cardiovascular systems, blood glucose monitoring systems, and electronic devices.

The cardiac and vascular company's cardiovascular business offers products and solutions for vascular interventions and surgical treatments through Terumo interventional systems, Terumo cardiovascular, and Terumo aortic, including access devices, endovascular therapies, oxygenators, and surgical grafts supporting minimally invasive and open cardiovascular procedures. Terumo Corp. has a market reach in over 160 countries and regions, operating 99 consolidated subsidiaries, 29 production sites, and 22 R&D sites.

Financial Highlights (FY 2025)

Company's Business Segments

• Cardiac and Vascular Company : Terumo Cardiovascular Develops, Manufactures Medical Devices that function outside the body in place of the heart and lungs during Cardiac Surgery.
• Medical Care Solutions Company : This segment includes Neurovascular Services, Hospital Care Solutions, Life Care Solutions, Pharmaceutical Solutions.
• Blood and Cell Technologies Company : The Blood and Cell Technologies Company provides solutions to Safely and Effectively process Donated Blood into Blood Products, Collect Blood Components needed for Transfusions, Cell Therapy.